Login / Signup

Comprehensive analysis of Methylenetetrahydrofolate reductase C677T in younger acute lymphoblastic leukemia patients: A single-center experience.

Rim FrikhaTarek RebaiBen Mahmoud LobnaFakher FrikhaMoez MdhaffarImen FrikhaMoez ElloumiNouha Bouayed
Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2018)
Our findings suggest that C677T polymorphism of MTHFR seems to be a good marker for MTX-related toxicity in ALL.
Keyphrases
  • acute lymphoblastic leukemia
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • allogeneic hematopoietic stem cell transplantation